Nrf2 protective mechanisms in rheumatoid arthritis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033466

Enrollment

Unknown

Registered

2020-06-01

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

OA group:Nil

RA group:Nil

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. All the RA patients should meet the 1987 ACR RA criteria or 2010 ACR/EULAR early RA criteria.ALL the OA patients should meet the 1995 ACR OA criteria.

Exclusion criteria

Exclusion criteria: 1. Patients aged over 70 years; 2. Patients with diabetes, obesity, virus infection, and malignant tumor; severe respiratory diseases, mental diseases, and pregnancy or lactation; 3. Patients with other autoimmune diseases: systemic lupus erythematosus, scleroderma, (dermatomyositis), nodular polyarteritis, cryoglobulinemia, glomerulonephritis, etc.

Design outcomes

Primary

Measure	Time frame
Expression level of nrf2 protein expression level;	—

Countries

China

Contacts

Public ContactYu Du

Shanghai Sixth People's Hospital

samanthadu@foxmail.com+86 18817615776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026